Your search
Results 70 resources
-
HCV-Positive Organ Donors In patients without hepatitis C virus infection who received a heart or lung from HCV-infected donors, 4 weeks of antiviral treatment initiated after surgery rendered all 35 recipients who had completed 6 months of follow-up free of HCV infection despite early signs of infection in 96% of the recipients within hours after surgery.
-
Hyperammonemia, in the absence of significant liver dysfunction, is an uncommon but often fatal occurrence following orthotopic lung transplant. Prior reports have provided evidence to support Ureaplasma species as an etiology for this syndrome. This case report describes an individual post-lung transplant, treated emperically with doxycycline along with other measures to lower ammonia levels, at the time hyperammonemia with encephalopathy was recognized. The patient clinically improved....
-
Invasive and disseminated Mycoplasma hominis infections are well recognized but uncommon complications in solid organ transplant recipients. In a single center, a cluster of M. hominis infections were identified in lung transplant recipients from the same thoracic intensive care unit (ICU). We sought to determine the source(s) of these infections.Medical records of the donor and infected transplant recipients were reviewed for clinical characteristics. Clinical specimens underwent routine...
-
Vibrio parahemolyticus is the leading cause of vibrio-associated gastroenteritis in the United States of America, usually related to poor food handling; only rarely has it been reported to cause serious infections including sepsis and soft tissue infections. In contrast, Vibrio vulnificus is a well-known cause of septicaemia, especially in patients with cirrhosis. We present a patient with V. parahemolyticus sepsis who had an orthotic liver transplant in 2007 and was on immunosuppression for...
-
Background Among lung transplant recipients, serial bronchoscopies are performed frequently. Often, serial galactomannan (GM), 1,3-β-d-glucan (BDG), and Pneumocystis jirovecii (PJ) testing is performed with these broncho-alveolar lavages (BALs) as standard of care with limited data to support their routine use. Methods After Institutional Review Board approval, we retrospectively collected all blood and BAL GM, BDG, and PJ test results from January 2015 to July 20, 2022. Primary data...
-
Background Transplanting lungs from donors with positive blood cultures has not been shown to adversely affect survival. There is limited evidence for potential effects on other outcomes, such as hospital course, graft function, and transmission of infection. Methods This retrospective cohort study included adult patients who underwent lung-only transplantation for the first time between March 2010 and December 2022. Outcomes of patients whose donors had positive blood cultures within 72 h...
-
Inhaled formulations of amphotericin B are the most widely used antifungal prophylactic agents in lung transplant recipients, yet there are limited data on their safety. We performed a single-center retrospective cohort study of 603 consecutive patients who underwent lung transplantation between 2012 and 2017 and received antifungal prophylaxis with inhaled amphotericin B lipid complex (iABLC) from the day of transplantation until hospital discharge. Of 603 patients, 600 (99.5%) received ≥1...
-
Background. With increasing life expectancy, patients with HIV are more commonly acquiring other chronic diseases, such as end-stage lung disease, for which transplant may be the only effective solution. Until recently, HIV infection was considered a contraindication to lung transplant (LTx). As LTx in people living with HIV (PLWH) becomes more common, there remain limited data on outcomes in this population. Methods. Using the Organ Procurement and...
Filter by our tag
GUIDELINES
- ISHLT Guidelines (5)
TEXTBOOKS
CORE CURRICULUM
- INTRO SOLID ORGAN TRANSPLANT (1)
-
ORGANISMS
(1)
- Bacteria (1)
ORGANISMS
- BACTERIA (14)
-
FUNGI
(8)
- Aspergillus (5)
- Candida (3)
- Cryptococcus (1)
- Dimorphic mycoses (1)
- Mucormycosis (1)
-
VIRUSES
(16)
- CMV (2)
- COVID-19 (1)
- Hepatitis C (3)
- HIV (4)
- Influenza (1)
- Measles (1)
- Polyomaviruses (1)
- Respiratory Viruses (5)
- RSV (2)
- VZV (1)
DIAGNOSTICS
DRUGS AND THERAPIES
- Antibiotics (1)
- Antifungals (6)
- Phage therapy (2)
PREVENTION
- Vaccination (1)
SOLID ORGANS AND MCSS
ATC 2024 Top Papers in TID
- BACTERIA (1)